Scientia Ventures
Scientia
About
Portfolio
People
Podcasts
Portfolio
People
Podcasts
News
About
Episode Summary
Harry welcomes back Andrew A. Radin, CEO of the drug discovery startup twoXAR, where scientists model pathogenesis computationally to identify potential drug molecules and, ideally shaving years off the drug development process.
Pod
Cast